Literature DB >> 15100312

Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.

Rachel M McLoughlin1, Suzanne M Hurst, Mari A Nowell, Dean A Harris, Sankichi Horiuchi, Llinos W Morgan, Thomas S Wilkinson, Naoki Yamamoto, Nicholas Topley, Simon A Jones.   

Abstract

Interleukin-6 signaling via its soluble receptor (sIL-6R) differentially regulates inflammatory chemokine expression and leukocyte apoptosis to coordinate transition from neutrophil to mononuclear cell infiltration. sIL-6R activities may, however, be influenced in vivo by the occurrence of two sIL-6R isoforms that are released as a consequence of differential mRNA splicing (DS) or proteolytic cleavage (PC) of the cognate IL-6R (termed DS- and PC-sIL-6R). Using human peritoneal mesothelial cells and a murine model of peritoneal inflammation, studies described in this work have compared the ability of both isoforms to regulate neutrophil recruitment. In this respect, DS- and PC-sIL-6R were comparable in their activities; however, these studies emphasized that IL-6 trans signaling differentially controls neutrophil-activating CXC chemokine expression. In vitro, stimulation of mesothelial cells with IL-6 in combination with either DS-sIL-6R or PC-sIL-6R showed no induction of CXC chemokine ligand (CXCL)1 (GRO alpha) and CXCL8 (IL-8), whereas both isoforms enhanced CXCL5 (ENA-78) and CXCL6 (granulocyte chemotactic protein-2) expression. Moreover, when complexed with IL-6, both isoforms specifically inhibited the IL-1 beta-induced secretion of CXCL8. These findings were paralleled in vivo, in which induction of peritoneal inflammation in IL-6-deficient (IL-6(-/-)) mice resulted in enhanced keratinocyte-derived chemokine and macrophage-inflammatory protein-2 (the murine equivalent of CXCL1 and CXCL8) levels, but reduced LPS-induced CXC chemokine (the murine equivalent of CXCL5) expression. Reconstitution of IL-6 signaling in IL-6(-/-) mice with IL-6 and its soluble receptor isoforms corrected this chemokine imbalance and suppressed overall neutrophil infiltration. These data confirm that sIL-6R-mediated signaling primarily limits neutrophil influx; however, induction of CXCL5 and CXCL6 may regulate other neutrophil responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100312     DOI: 10.4049/jimmunol.172.9.5676

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Authors:  Owen W Stephens; Qing Zhang; Pingping Qu; Yiming Zhou; Shweta Chavan; Erming Tian; David R Williams; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

Review 2.  Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance.

Authors:  Trupti D Vardam; Lei Zhou; Michelle M Appenheimer; Qing Chen; Wang-Chao Wang; Heinz Baumann; Sharon S Evans
Journal:  Cytokine       Date:  2007-07       Impact factor: 3.861

3.  Lymphocytes modulate peritoneal leukocyte recruitment in peritonitis.

Authors:  T Kipari; S Watson; K Houlberg; S Lepage; J Hughes; Jean-François Cailhier
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

Review 4.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

Authors:  Simon A Jones; Jürgen Scheller; Stefan Rose-John
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

5.  Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature.

Authors:  Ramsi Haddad; Gerard Tromp; Helena Kuivaniemi; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Moshe Mazor; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2006-08       Impact factor: 8.661

Review 6.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

7.  The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling.

Authors:  Melanie Leggate; Mari A Nowell; Simon A Jones; Myra A Nimmo
Journal:  Cell Stress Chaperones       Date:  2010-04-16       Impact factor: 3.667

8.  Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.

Authors:  Yuping Wang; David F Lewis; Yang Gu; Shuang Zhao; Lynn J Groome
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

9.  Keratinocytes produce IL-6 in response to desmoglein 1 cleavage by Staphylococcus aureus exfoliative toxin A.

Authors:  Cleo E Rolle; Juan Chen; Irena Pastar; Tatiana C P Cardenas; Roberto Perez; Suzanne Hower; Franco Ferracci; Richard Snyder; Marjana Tomic-Canic; Lisa R W Plano
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 10.  The varying faces of IL-6: From cardiac protection to cardiac failure.

Authors:  Jillian A Fontes; Noel R Rose; Daniela Čiháková
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.